Form 4 for EW Edwards Lifesciences
Accepted 2024-02-12 00:00:00 ET · period of report 2024-02-12 · accession 0001225208-24-001867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-12 | 2024-02-12 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | M - OptEx | $36.75 | +12.2K | 25.3K | +93% | +$448.7K |
| D | 2024-02-12 | 2024-02-12 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | S - Sale+OE | $87.00 | -12.2K | 13.1K | -48% | -$1.06M |
| D | 2024-02-12 | 2024-02-12 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | M - OptEx | $0.00 | -12.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-12 | M | A | 12,210 | $36.75 | 25,297.18 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-12 | S | D | 12,210 | $87.00 | 13,087.18 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2024-02-12 | M | D | 12,210 | $0.00 | 0 | D | $36.75 · 2018-05-11 to 2024-05-10 | 12,210 Common Stock |